Antiproliferative effect of dehydrodidemnin B (DDB), a depsipeptide isolated from Mediterranean tunicates

Cancer Letters

Volumn 102, Issue 1-2, 1996, Pages 31-37

  Urdiales, José L ^a   Morata, Pilar ^a   De Castro, Ignacio Núñez ^a   Sánchez Jiménez, Francisca ^a  

^a UNIVERSITY OF MÁLAGA   (Spain)

Author keywords

Anticancer; Dehydrodidemnin B; Didemnin B; Ornithine decarboxylase; Tumour growth

Indexed keywords

DEHYDRODIDEMNIN B; DEPSIPEPTIDE; DIDEMNIN B; ORNITHINE DECARBOXYLASE; PROTEIN SYNTHESIS INHIBITOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; EHRLICH ASCITES TUMOR; ENZYME INHIBITION; INTRAPERITONEAL DRUG ADMINISTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS INHIBITION;

ANIMALIA; APLIDIUM; UROCHORDATA;

EID: 0029670281     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/0304-3835(96)04151-1     Document Type: Article

References (29)

1. Rinerhart, Jr., K.L., Gloer, J.B., Hughes, Jr., R.G., Renis, H.E., McGovern, J.P., Swynenberg, E.B., Stringfellow, D.A., Kuentzel, S.L. and Li, L.H. (1981) Didemnins: antiviral and antitumor depsipeptides from a Caribbean tunicate. Science, 212, 933-935.
2. Rinerhart, Jr., K.L., Gloer, J.B., Wilson, G.R., Hughes, R.G. Jr., Li, L.H., Renis, H.E. and McGovern, J.P. (1983) Antiviral and antitumor compounds from tunicates. Fed. Proc., 42, 87-90.
3. Montgomery, D.W., Shen, G.K., Ulrich, E.D. and Zukoski, C.F. (1994) Immunomodulation by didemnins. Invertebrate marine natural products. Ann. N. Y. Acad. Sci., 712, 301-314.
4. Hossain, M.B., van der Helm, D., Antel, J., Sheldrick, G.M., Sanduja, S.K. and Weinheimer, A.J. (1988) Crystal and molecular structure of didemnin B, and antiviral and cytotoxic depsipeptide. Proc. Natl. Acad. Sci. USA, 85, 4118-4122.
5. Li, L.H., Timmins, L.G., Wallace, T.L., Krueger, W.C., Prairie, M.D. and Im, W.B. (1984) Mechanism of action of didemnin B, a depsipeptide from the sea. Cancer Lett., 23, 279-288.
6. Gschwendt, M., Kiistein, W. and Marks, F. (1987) Didemnin B inhibits biological effects of tumour promoting phorbol esters on mouse skin, as well as phosphorylation of a 100 kDa protein in mouse epidermis cytosol. Cancer Lett., 34, 187-191.
7. Crews, C.M., Collins, J.L., Lane, W.S., Snapper, M.L. and Schereiber, S.L. (1994) GTP-dependent binding of the antiproliferative agent didemnin to elongation factor 1a. J. Biol. Chem., 269, 15411-15414.
8. Crampton, S.L., Adams, E.G., Kuentzel, S.L., Li, L.H., Badiner, G. and Bhuyan, B.K. (1984) Biochemical and cellular effects of didemnins A and B. Cancer Res., 44, 1795-1801.
9. Shin, D.M., Holoye, P.Y., Forman, A., Winn, R., Pérez-Soler, R., Dakhil, S., Rosenthal, J., Raber, M.N. and Hong, W.K. (1994) Phase II clinical trial of didemnin B in previously treated small cell lung cancer. Invest. New Drugs, 12, 243-249.
10. Sondak, V.K., Kopecky, K.J., Liu, P.V., Fletcher, W.S., Harvey, W.H. and Laufman, L.R. (1994) Didemnin B in metastatic malignant melanoma: a phase II trial of the Southwest Oncology group. Anticancer Drugs, 5, 147-150.
11. Weiss, R.B., Peterson, B.L., Allen, S.L., Browning, S.M., Duggan, D.B. and Schiffer, C.A. (1994) A phase II trial of didemnin B in myeloma. A Cancer and Leukemia Group B (CALGB) study. Invest. New Drugs, 12, 41-43.
12. Jouin, P., Poncet, J., Dufour, M.N., Aumelas, A., Pantaloni, A., Cros, S. and Francois, G. (1991) Antineoplastic activity of didemnin congeners: nordidemnin and modified chain analogs. J. Med. Chem., 34, 486-491.
13. Carrascosa, J.M., Martínez, P. and Núñez de Castro, I. (1984) Nitrogen movement between host and tumor in mice inoculated with Ehrlich ascitic tumor cells. Cancer Res., 44, 3831-3835.
14. Urdiales, J.L., Matés, J.M., Núñez de Castro, I. and Sánchez-Jiménez, F. (1992) Chlorpheniramine inhibits the ornithine decarboxylase induction of Ehrlich carcinoma growing in vivo. FEBS Lett., 305, 260-264.
15. Hasen, M.B., Nielsen, S.E. and Berg, K. (1989) Reexamination and further development of a precise rapid dye method for measuring cell growth/cell kill. J. Immunol. Methods, 119, 203-210.
16. Bradford, M.M. (1976) A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem., 72, 248-254.
17. Sánchez-Jiménez, F., Urdiales, J.L., Matés, J.M. and Núñez de Castro, I. (1992) The induction of ornithine decarboxylase by ornithine takes place at post-transcriptional level in perifused Ehrlich carcinoma cells. Cancer Lett., 67, 187-192.
18. Medina, M.A., García de Veas, R., Morata, P., Lozano, J. and Sánchez-Jiménez, F. (1995) Chlorpheniramine inhibits the synthesis of ornithine decarboxylase and the proliferation of human breast cancer cell lines. Breast Cancer Res. Treat., 35, 187-194.
19. Rudkin, B.B., Mamont, P.S. and Seiler, N. (1984) Decreased protein-synthetic activity is an early consequence of spermidine depletion in rat hepatoma tissue-culture cells. Biochem. J., 217, 731-741.
20. Dorr, F.A., Kuhn, J.G., Phillips, J. and von Hoff, D.D. (1988) Phase I clinical and pharmacokinetic investigation of didemnin B, a cyclic depsipeptide. Eur. J. Cancer Clin. Oncol., 24, 1699-1706.
21. Gil-Torregrosa, B., Urdiales, J.L., Lozano, J., Matés, J.M. and Sánchez-Jiménez, F. (1994) Expression of different mitogen-regulated protein/proliferin mRNAs in Ehrlich carcinoma cells. FEBS Lett., 349, 343-348.
22. Johannes, G. and Berger, F.G. (1992) Alterations in mRNA translation as a mechanism for the modification of enzyme synthesis during evolution. J. Biol. Chem., 267, 10108-10115.
23. Auvinen, M., Paasinen, A., Andersson, L.C. and Ĥltt%o, E. (1992) Ornithine decarboxylase activity is critical for cell transformation. Nature, 360, 355-358.
24. Hölttä, E., Auvinen M., Paasinen, A., Kangas, A. and Andersson, L.C. (1994) Ornithine decarboxylase-induced cellular transformation: the involvement of protein tyrosine kinase(s) and pp130. Biochem. Soc. Trans., 22, 853-859.
25. Heby, O. and Persson, L. (1990) Molecular genetics of polyamine synthesis in eukaryotic cells. Trends Biochem. Sci., 15, 153-158.
26. Morata, P., Jiménez-Mesa, P., Núñez de Castro, I. and Sánchez-Jiménez, F. (1994) Vinca alkaloids enhance the half-life of tumour ornithine decarboxylase. Cancer Lett., 81, 209-213.
27. Viguera, E., Trelles, O., Urdiales, J.L., Matés, J.M. and Sánchez-Jiménez F. (1994) Mammalian L-amino acid decarboxylases producing 1,4-diamines: analogies among differences. Trends Biochem. Sci., 19, 318-319.
28. Russell, D.H., Buckley, A.R., Montgomery, D.W., Larson, N.A., Gout, P.W., Beer, C.T., Putnam, C.W., Zukoski, C.F. and Kibler, R. (1987) Prolactin-dependent mitogenesis in Nb2 lymphoma cells: effects of immunosuppressive cyclopeptides. J. Immunol., 138, 276-284.
29. Schulze-Lohoff, E., Fees, H., Zanner, S., Brand, K. and Sterzel, R.B. (1994) Inhibition of immediate-early-gene induction in renal mesangial cells by depletion of intracellular polyamines. Biochem. J., 298, 647-653.